1345.HK
Strong BuyFull HouseAI screen passShanghai Pioneer Holding Ltd · Healthcare · China · $331M
HKD 2.12 +0.0% · close 6 Oct · scored 7 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Shanghai Pioneer Holding operates a diversified marketing and distribution network for imported pharmaceutical products and medical devices across China. The business generates durable cash flows supported by robust operating margins and a modest valuation relative to cash generation.
ABOUT SHANGHAI PIONEER HOLDING LTD
Read
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.8B | 1.8B | 1.8B | 1.5B | -6.2% | 1.5B |
| EPS (HKD) | 0.23 | 0.14 | 0.15 | 0.12 | -20.6% | 0.13 |
| Shares | 1.3B | 1.2B | 1.2B | 1.2B | -7.8% | 1.2B |
| Debt | 44.1M | 86.8M | 88.2M | 142.3M | 47.8% | 255.2M |
| Equity | 1.2B | 1.2B | 1.3B | 1.2B | 1.4% | — |
| Op CF | 109.4M | -139.2M | 251.9M | 245.4M | 30.9% | 256.5M |
| Inv CF | -15.2M | 81.5M | -117.0M | -97.8M | — | — |
| Fin CF | -106.7M | -59.3M | -147.6M | -73.7M | — | — |
Calmer than 61% of stocks we rank over the past year (36% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1345.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1345.HK | Shanghai Pioneer Holding Ltd(you) | $331M | 97 | Strong Buy |
| 9885.HK | YSB Inc. | $297M | 89 | Strong Buy |
| 002727.SZ | Yixintang Pharmaceutical Group Co., Ltd. | $925M | 87 | Strong Buy |
| 603883.SS | LBX Pharmacy Chain Joint Stock Company | $1.5B | 89 | Strong Buy |
| 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $3.0B | 96 | Strong Buy |
| 603939.SS | Yifeng Pharmacy Chain Co., Ltd. | $4.0B | 94 | Strong Buy |
| 301408.SZ | Anhui Huaren Health Pharmaceutical Co., Ltd. | $885M | 61 | Hold |
| 002788.SZ | Luyan Pharma Co.,Ltd. | $630M | 47 | Hold |
| 301017.SZ | ShuYu Civilian Pharmacy Corp., Ltd. | $800M | 50 | Hold |
| 6086.HK | Fangzhou Inc. | $136M | 46 | Hold |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 53.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.